Tuesday, August 18, 2026

No Result

View All Result

No Result

View All Result

No Result

View All Result

Home Tag feature stories

Tag: feature stories

Clinical Chemistry

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

by admin

Zurich, Switzerland - Polaroid Therapeutics (PTx), a Swiss biotechnology company advancing evidence-based antimicrobial polymer and wound care technologies, has announced ...

Accreditation

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

by admin

May 30, 2026

The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also noting last year’s Phase ...

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

July 23, 2026

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

May 30, 2026

Welcome Back!

Remember Me

Forgotten Password?

No Result

View All Result

Tag: feature stories

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Stay Connected

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Recent News

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Arab Health World

Recent News

Polaroid Therapeutics Announces Membership with Crohn’s & Colitis Foundation’s IBD Plexus to Advance IBD Research

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Follow Us

Welcome Back!

Retrieve your password

Add New Playlist